OBI-3424

FDA Approves IND for OBI Pharma's OBI-3424 for a Ph I/II Study in AKR1C3 Solid Tumors
CP Wire
Thu, 04/19/18 - 09:13 am
OBI Pharma
FDA
OBI-3424
FDA Approves IND for OBI Pharma's OBI-3424 for a Ph I/II Study in AKR1C3 Solid Tumors
Thu, 04/19/18 - 08:35 am
OBI Pharmaceuticals
OBI-3424